APA (7th ed.) Citation

Leng, W., Wen, Z., Wang, H., Cao, P., Liu, J., Luo, D., & Qiu, M. Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic colorectal cancer: Study protocol for a multicenter, prospective, single-arm, phase II trial. BMC.

Chicago Style (17th ed.) Citation

Leng, Weibing, Zhenpeng Wen, Han Wang, Peng Cao, Jiyan Liu, Deyun Luo, and Meng Qiu. Raltitrexed, S-1 and Fruquintinib (RSF) in the Treatment of Refractory Metastatic Colorectal Cancer: Study Protocol for a Multicenter, Prospective, Single-arm, Phase II Trial. BMC.

MLA (9th ed.) Citation

Leng, Weibing, et al. Raltitrexed, S-1 and Fruquintinib (RSF) in the Treatment of Refractory Metastatic Colorectal Cancer: Study Protocol for a Multicenter, Prospective, Single-arm, Phase II Trial. BMC.